Date: 2016-09-21
Type of information: Construction of new premises
Compound: packaging building in Darmstadt, Germany
Company: Merck KGaA (Germany)
Therapeutic area:
Type agreement: construction of new premises
Action mechanism:
Disease:
Details: * On September 21, 2016, Merck KGaA announced an investment of more than € 50 million in a state-of-the-art packaging building at its pharmaceutical manufacturing site in Darmstadt, Germany. Darmstadt is Merck KGaA's largest site and center of excellence for oral and solid dosage forms and this new center of excellence will enable the packaging of more than 400 million blisters or 150 million packs annually. It will use energy-saving technologies, and forms part of Merck’s strategy to sustainably secure its leading position in healthcare manufacturing. It is aligned with other investments across Merck’s manufacturing network worldwide and aims to further strengthen the company’s manufacturing footprint and upgrade its services for patients. Construction of the state-of-the-art 15,000 square meter packaging building is planned to be completed by the end of 2017 and expected to be operational as of mid-2018. The center will be designed to comply with the highest international GMP quality standards. In Darmstadt, Merck KGaA is committed to invest around € 1 billion until 2020 and this investment is part of this initiative.
Financial terms:
Latest news:
